Sowell Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$502K Buy
2,639
+186
+8% +$32K 0.02% 648
2026
Q1
$414K Sell
2,453
-218
-8% -$37.3K 0.02% 706
2025
Q4
$451K Buy
2,671
+101
+4% +$16.4K 0.02% 680
2025
Q3
$371K Buy
2,570
+20
+0.8% +$2.73K 0.01% 741
2025
Q2
$323K Sell
2,550
-304
-11% -$37.3K 0.01% 753
2025
Q1
$365K Buy
+2,854
New +$387K 0.02% 683
2023
Q2
– Sell
-3,126
Closed -$404K – 670
2023
Q1
$404K Buy
+3,126
New +$409K 0.03% 493
2021
Q2
– Sell
-1,571
Closed -$233K – 1517
2021
Q1
$233K Buy
1,571
+18
+1% +$2.86K 0.01% 969
2020
Q4
$235K Buy
1,553
+43
+3% +$6.14K 0.01% 783
2020
Q3
$205K Sell
1,510
-1,061
-41% -$144K 0.01% 718
2020
Q2
$351K Buy
2,571
+1,455
+130% +$185K 0.02% 551
2020
Q1
$120K Buy
1,116
+29
+3% +$3.34K 0.01% 791
2019
Q4
$131K Hold
1,087
– – 0.01% 832
2019
Q3
$108K Buy
+1,087
New +$114K 0.01% 804
2017
Q1
– Sell
-450
Closed -$44K – 401
2016
Q4
$44K Buy
+450
New +$41K 0.01% 355

Other funds holding IBB

Sowell Financial Services's IBB Position: Q2 2026 in Review

Sowell Financial Services increased its iShares Biotechnology ETF (IBB) stake by 7.6% in Q2 2026, buying an estimated $32K and bringing the position to 2,639 shares worth $502K. The position accounts for 0.02% of the portfolio, ranked #648.

Sowell Financial Services first reported a position in IBB in Q4 2016 and has held it in 15 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Sowell Financial Services held 2,639 shares of iShares Biotechnology ETF worth $502K as of Q2 2026.
  • Sowell Financial Services bought 186 iShares Biotechnology ETF shares in Q2 2026, an estimated $32K.
  • iShares Biotechnology ETF made up 0.02% of Sowell Financial Services's portfolio in Q2 2026, its #648 holding.
  • Sowell Financial Services first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 15 quarters since.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.